What Woodline Partners LP changed, 2019 to 2026
27 quarterly 13F filings, from Q4 2019 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$32.4bn
$2.4bn at Q4 2019
Positions
1,011
105 at Q4 2019
Top ten weight
17%
27% at Q4 2019
Typical quarterly turnover
about 38%
Estimated from share changes
- Q4 2019: $2.4bn
- Q1 2020: $1.4bn
- Q2 2020: $2.5bn
- Q3 2020: $3.1bn
- Q4 2020: $3.8bn
- Q1 2021: $4.5bn
- Q2 2021: $5.4bn
- Q3 2021: $6.1bn
- Q4 2021: $7.0bn
- Q1 2022: $6.2bn
- Q2 2022: $6.5bn
- Q3 2022: $7.2bn
- Q4 2022: $7.5bn
- Q1 2023: $7.4bn
- Q2 2023: $8.4bn
- Q3 2023: $8.5bn
- Q4 2023: $9.2bn
- Q1 2024: $10.9bn
- Q2 2024: $10.5bn
- Q3 2024: $11.9bn
- Q4 2024: $14.8bn
- Q1 2025: $15.4bn
- Q2 2025: $18.9bn
- Q3 2025: $21.2bn
- Q4 2025: $25.8bn
- Q1 2026: $26.4bn
- Q2 2026: $32.4bn
- Q4 2019: 27%
- Q1 2020: 30%
- Q2 2020: 26%
- Q3 2020: 28%
- Q4 2020: 22%
- Q1 2021: 19%
- Q2 2021: 20%
- Q3 2021: 16%
- Q4 2021: 16%
- Q1 2022: 16%
- Q2 2022: 18%
- Q3 2022: 17%
- Q4 2022: 16%
- Q1 2023: 17%
- Q2 2023: 16%
- Q3 2023: 17%
- Q4 2023: 15%
- Q1 2024: 14%
- Q2 2024: 15%
- Q3 2024: 12%
- Q4 2024: 13%
- Q1 2025: 12%
- Q2 2025: 15%
- Q3 2025: 16%
- Q4 2025: 19%
- Q1 2026: 17%
- Q2 2026: 17%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q4 2019 | $1.1bnQ2 2026 | $1.1bn | |
| Apple Inc(AAPL) | Q1 2020 | $927mQ2 2026 | $927m | |
| Microsoft Corp(MSFT) | Q3 2021 | $630mQ4 2025 | $607m | |
| Amazon Com Inc(AMZN) | Q1 2020 | $588mQ2 2026 | $588m | |
| Facebook Inc(META)Class A | Q4 2019 | $463mQ2 2026 | $463m | |
| Broadcom Inc(AVGO) | Q1 2021 | $444mQ2 2026 | $444m | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q1 2020 | $412mQ1 2026 | $396m | |
| Revolution Medicines Inc(RVMD) | Q1 2020 | $375mQ2 2026 | $375m | |
| Alphabet Inc(GOOG)Capital Stock Class C | Q4 2024 | $362mQ2 2026 | $362m | |
| Micron Technology Inc(MU) | Q4 2019 | $317mQ2 2026 | $317m | |
| Lilly Eli & Co(LLY) | Q4 2019 | $294mQ2 2026 | $294m | |
| Tesla Inc(TSLA) | Q4 2021 | $270mQ2 2026 | $270m | |
| iShares Core S&P500 ETF(IVV) | Q4 2025 | $1.0bnQ4 2025 | Soldlast listed Q4 2025 | |
| Spdr S&P 500 Etf Trust(SPY) | Q3 2021 | $366mQ2 2022 | Soldlast listed Q1 2023 | |
| Activision Blizzard Inc | Q4 2019 | $238mQ3 2023 | Soldlast listed Q3 2023 | |
| Te Connectivity LTD | Q1 2022 | $215mQ1 2024 | Soldlast listed Q2 2024 | |
| Seagen Inc | Q4 2020 | $203mQ1 2022 | Soldlast listed Q3 2023 | |
| Ovintiv Inc(OVV) | Q3 2023 | $190mQ2 2024 | Below the listed rangelast listed Q2 2025 | |
| Travelers Companies Inc(TRV) | Q4 2024 | $163mQ4 2025 | Soldlast listed Q1 2026 | |
| Merus N V | Q4 2021 | $158mQ3 2025 | Soldlast listed Q3 2025 |
Quarter by quarter
Q2 2024: $10.5bn across 545 positions
Against Q1 2024: 188 new, 182 added to, 155 trimmed, 171 sold out, across all 545 positions.
Turnover about 38% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Chord Energy Corporation (CHRD)+$99m
- Quest Diagnostics Inc (DGX)+$90m
- Sensata Technologies HLDNG P (ST)+$74m
- Civitas Resources Inc+$69m
- Geron Corp (GERN)+$68m
- Boston Scientific Corp (BSX)+$67m
- Nuvalent Inc (NUVL)+$62m
- Morphic HLDG Inc+$57m
Largest reductions
- Avnet Inc (AVT)-$126m
- Datadog Inc (DDOG)-$67m
- Amazon Com Inc (AMZN)-$66m
- Apple Inc (AAPL)-$57m
- Te Connectivity LTD-$54m
- Expedia Group Inc (EXPE)-$53m
- Parker-hannifin Corp (PH)-$48m
- Antero Resources Corp (AR)-$41m
Opened
- Marsh & Mclennan Cos Inc (MRSH)$123m
- Electronic Arts Inc (EA)$102m
Sold out
- Analog Devices Inc (ADI)was $138m
- Enerplus Corpwas $110m
- Pioneer Nat Res Cowas $74m
- Honeywell Intl Inc (HON)was $73m
- Avantor Inc (AVTR)was $72m
- West Pharmaceutical SVSC Inc (WST)was $66m
- Asml Holding N V (ASML)was $66m
- Ameriprise Finl Inc (AMP)was $49m
Largest positions, Q2 2024
The largest 25 of 545 reported positions; the largest 500 carry 99.8% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Lilly Eli & Co (LLY) | $258m | 2.5% | Trimmed |
| Regeneron Pharmaceuticals (REGN) | $191m | 1.8% | Added |
| Ovintiv Inc (OVV) | $190m | 1.8% | Added |
| Te Connectivity LTD | $161m | 1.5% | Trimmed |
| Abbvie Inc (ABBV) | $129m | 1.2% | Added |
| Revolution Medicines Inc (RVMD) | $128m | 1.2% | Trimmed |
| Chord Energy Corporation (CHRD) | $126m | 1.2% | Added |
| Facebook Inc (META) | $125m | 1.2% | Added |
| Marsh & Mclennan Cos Inc (MRSH) | $123m | 1.2% | New |
| Permian Resources Corp (PR) | $113m | 1.1% | Added |
| Quest Diagnostics Inc (DGX) | $107m | 1.0% | Added |
| Civitas Resources Inc | $103m | 1.0% | Added |
| Electronic Arts Inc (EA) | $102m | 1.0% | New |
| Progressive Corp (PGR) | $100m | 1.0% | Added |
| Zimmer Biomet HLDGS Inc (ZBH) | $100m | 1.0% | Added |
| Gallagher Arthur J & Co (AJG) | $98m | 0.9% | Added |
| Blueprint Medicines Corp | $95m | 0.9% | Added |
| Fortive Corp (FTV) | $93m | 0.9% | Added |
| Amgen Inc (AMGN) | $91m | 0.9% | Added |
| Merck & Co. Inc (MRK) | $88m | 0.8% | Trimmed |
| Keysight Technologies Inc (KEYS) | $85m | 0.8% | Added |
| Roivant Sciences LTD (ROIV) | $85m | 0.8% | Trimmed |
| Sensata Technologies HLDNG P (ST) | $82m | 0.8% | Added |
| Eqt Corp (EQT) | $81m | 0.8% | Added |
| Boston Scientific Corp (BSX) | $79m | 0.8% | Added |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| T. Rowe Price Associates Inc | at least 42% | 234 | Compare | |
| Wellington Management Group LLP | at least 42% | 227 | Compare | |
| Fidelity (FMR LLC) | at least 40% | 236 | Compare | |
| Invesco Ltd | at least 40% | 241 | Compare | |
| AllianceBernstein LP | at least 40% | 232 | Compare | |
| Neuberger Berman Group LLC | at least 40% | 197 | Compare | |
| Janus Henderson Group Ltd | at least 39% | 207 | Compare | |
| Acadian Asset Management LLC | at least 36% | 162 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Woodline Partners LP | $32.4bn | 13F-HR | |
| Q1 2026 | Woodline Partners LP | $26.4bn | 13F-HR | |
| Q4 2025 | Woodline Partners LP | $25.8bn | 13F-HR | |
| Q3 2025 | Woodline Partners LP | $21.2bn | 13F-HR | |
| Q2 2025 | Woodline Partners LP | $18.9bn | 13F-HR | |
| Q1 2025 | Woodline Partners LP | $15.4bn | 13F-HR | |
| Q4 2024 | Woodline Partners LP | $14.8bn | 13F-HR | |
| Q3 2024 | Woodline Partners LP | $11.9bn | 13F-HR | |
| Q2 2024 | Woodline Partners LP | $10.5bn | 13F-HR | |
| Q1 2024 | Woodline Partners LP | $10.9bn | 13F-HR | |
| Q4 2023 | Woodline Partners LP | $9.2bn | 13F-HR | |
| Q3 2023 | Woodline Partners LP | $8.5bn | 13F-HR | |
| Q2 2023 | Woodline Partners LP | $8.4bn | 13F-HR | |
| Q1 2023 | Woodline Partners LP | $7.4bn | 13F-HR | |
| Q4 2022 | Woodline Partners LP | $7.5bn | 13F-HR | |
| Q3 2022 | Woodline Partners LP | $7.2bn | 13F-HR | |
| Q2 2022 | Woodline Partners LP | $6.5bn | 13F-HR | |
| Q1 2022 | Woodline Partners LP | $6.2bn | 13F-HR | |
| Q4 2021 | Woodline Partners LP | $7.0bn | 13F-HR | |
| Q3 2021 | Woodline Partners LP | $6.1bn | 13F-HR | |
| Q2 2021 | Woodline Partners LP | $5.4bn | 13F-HR | |
| Q1 2021 | Woodline Partners LP | $4.5bn | 13F-HR | |
| Q4 2020 | Woodline Partners LP | $3.8bn | 13F-HR | |
| Q3 2020 | Woodline Partners LP | $3.1bn | 13F-HR | |
| Q2 2020 | Woodline Partners LP | $2.5bn | 13F-HR | |
| Q1 2020 | Woodline Partners LP | $1.4bn | 13F-HR | |
| Q4 2019 | Woodline Partners LP | $2.4bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More